China’s life sciences boom: Navigating risk for growth

Tuesday, March 10, 2026

10:00am – 11:00am CST (China Standard Time) 

China’s life sciences sector is experiencing rapid expansion, driven by innovation, regulatory reforms, and increasing global collaboration. For companies and investors, this growth could present significant opportunities – and complex challenges. Geopolitical shifts, evolving trade policies, and regulatory uncertainties could impact market entry and long-term strategy.

A panel of DLA Piper attorneys will explore:

• Key drivers of growth in China’s life sciences industry
• Strategic considerations for mergers and acquisitions, partnerships, licensing, and investment
• Managing geopolitical and compliance risks in cross-border transactions
• Changes resulting from the BIOSECURE Act and the operational steps life sciences and investors can take now

This session will provide practical insights for life sciences executives, investors, and legal teams seeking to engage with China’s dynamic market while mitigating risk.

We look forward to seeing you there.

For more information
Please contact Camille Tanksley.

CLE information

DLA Piper LLP (US) has been certified by the State Bar of California, the Illinois MCLE Board, the Board on Continuing Legal Education of the Supreme Court of New Jersey, and the New York State Continuing Legal Education Board as an Accredited Provider. The following CLE credit is being sought:

• California: 1.0 General Credit
• Illinois: 1.0 General Credit
• New Jersey: 1.2 General Credits
• New York: 1.0 Professional Practice Credit (Transitional/Appropriate for Newly Admitted & Experienced Attorneys)

CLE credit will be applied for in other states where DLA Piper has an office, with the exception of Minnesota, North Carolina, and Puerto Rico.